Source:http://linkedlifedata.com/resource/pubmed/id/21199794
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2011-1-4
|
pubmed:abstractText |
Mammalian target of rapamycin (mTOR) is a major downstream effector of the receptor tyrosine kinase (RTK)-phosphoinositide 3-kinase (PI3K)-v-akt murine thymoma viral oncogene homologue 1 (AKT) signaling pathway. Although this signaling network is frequently altered in cancer, the underlying mechanisms that cause tumorigenesis as a result of activated mTOR remain largely unknown. We report here that expression of lactate dehydrogenase B (LDHB), a critical enzymatic activator of glycolysis, was upregulated in an mTOR-dependent manner in TSC1(-/-), TSC2(-/-), PTEN(-/-), or activated AKT1-expressing mouse embryonic fibroblasts (MEF). LDHB gene expression was transactivated by signal transducer and activator of transcription 3 (STAT3), a key tumorigenic driver in many cancers, acting as a downstream mTOR effector in both mouse MEFs and human cancer cells. LDHB attenuation blunted the tumorigenic potential of oncogenic TSC2-null cells in nude mice. We concluded that LDHB is a downstream target of mTOR that is critical for oncogenic mTOR-mediated tumorigenesis. Our findings offer proof of concept for targeting LDHB as a therapeutic strategy in cancers driven by aberrant activation of the RTK-PI3K-AKT-mTOR signaling cascade.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/L-Lactate Dehydrogenase,
http://linkedlifedata.com/resource/pubmed/chemical/STAT3 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/TOR Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/lactate dehydrogenase 1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1538-7445
|
pubmed:author | |
pubmed:copyrightInfo |
© 2011 AACR.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
13-8
|
pubmed:dateRevised |
2011-5-31
|
pubmed:meshHeading |
pubmed-meshheading:21199794-Animals,
pubmed-meshheading:21199794-Cell Line, Tumor,
pubmed-meshheading:21199794-Cell Proliferation,
pubmed-meshheading:21199794-Cell Transformation, Neoplastic,
pubmed-meshheading:21199794-Cells, Cultured,
pubmed-meshheading:21199794-Chromatin Immunoprecipitation,
pubmed-meshheading:21199794-Humans,
pubmed-meshheading:21199794-Isoenzymes,
pubmed-meshheading:21199794-L-Lactate Dehydrogenase,
pubmed-meshheading:21199794-Mice,
pubmed-meshheading:21199794-Mice, Nude,
pubmed-meshheading:21199794-RNA Interference,
pubmed-meshheading:21199794-STAT3 Transcription Factor,
pubmed-meshheading:21199794-TOR Serine-Threonine Kinases
|
pubmed:year |
2011
|
pubmed:articleTitle |
Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis.
|
pubmed:affiliation |
State Key Laboratory of Medical Molecular Biology, Department of Physiology & Pathophysiology, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|